Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental data
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hartmann, A.
Right arrow Articles by Hirsch, E. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hartmann, A.
Right arrow Articles by Hirsch, E. C.
Related Collections
Right arrow Parkinson's disease/Parkinsonism
Neurology 2002;58:308-310
© 2002 American Academy of Neurology
Brief Communications

FADD: A link between TNF family receptors and caspases in Parkinson’s disease

A. Hartmann, MD, A. Mouatt–Prigent, B. A. Faucheux, PhD, Y. Agid, MD PhD; and E. C. Hirsch, PhD

From Institut National de la Santé et de la Recherche Médicale U 289, Hôpital de la Salpêtière, Paris, France.

Address correspondence and reprint requests to Dr. Etienne C. Hirsch, INSERM U 289, Hôpital de la Salpêtrière, 47 Boulevard de l’Hôpital, 75013 Paris, France; e-mail: hirsch{at}ccr.jussieu.fr

Fas-associating protein with a death domain (FADD) is a proximal adaptor protein of the tumor necrosis factor (TNF) receptor family death pathway. This human postmortem study showed a significant decrease in the percentage of FADD-immunoreactive dopaminergic (DA) neurons in the substantia nigra pars compacta of patients with PD compared with controls (-24.8%). This decrease correlated with the known selective vulnerability of nigral DA neurons in PD, suggesting that this pathway contributes to the susceptibility of DA neurons in PD to TNF-mediated apoptosis.




This article has been cited by other articles:


Home page
 BrainHome page
F. Simunovic, M. Yi, Y. Wang, L. Macey, L. T. Brown, A. M. Krichevsky, S. L. Andersen, R. M. Stephens, F. M. Benes, and K. C. Sonntag
Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology
Brain, July 1, 2009; 132(7): 1795 - 1809.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
L.-y. Yu, M. Saarma, and U. Arumae
Death Receptors and Caspases But Not Mitochondria Are Activated in the GDNF- or BDNF-Deprived Dopaminergic Neurons
J. Neurosci., July 23, 2008; 28(30): 7467 - 7475.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
P. Jenner
Preclinical evidence for neuroprotection with monoamine oxidase-B inhibitors in Parkinson's disease
Neurology, October 12, 2004; 63(7_suppl_2): S13 - S22.
[Full Text]

Home page
 J. Virol.Home page
R. Kassis, F. Larrous, J. Estaquier, and H. Bourhy
Lyssavirus Matrix Protein Induces Apoptosis by a TRAIL-Dependent Mechanism Involving Caspase-8 Activation
J. Virol., June 15, 2004; 78(12): 6543 - 6555.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
S. Hayley, S. J. Crocker, P. D. Smith, T. Shree, V. Jackson-Lewis, S. Przedborski, M. Mount, R. Slack, H. Anisman, and D. S. Park
Regulation of Dopaminergic Loss by Fas in a 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson's Disease
J. Neurosci., February 25, 2004; 24(8): 2045 - 2053.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
P. Hrycaj, I. Korczowska, and J. K. Lacki
Severe Parkinson's disease in rheumatoid arthritis patient treated with infliximab
Rheumatology, May 1, 2003; 42(5): 702 - 703.
[Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
G. A. de Erausquin, K. Hyrc, D. A. Dorsey, D. Mamah, M. Dokucu, D. H. Masco, T. Walton, K. Dikranian, M. Soriano, J. M. G. Verdugo, et al.
Nuclear Translocation of Nuclear Transcription Factor-kappa B by alpha -Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptors Leads to Transcription of p53 and Cell Death in Dopaminergic Neurons
Mol. Pharmacol., April 1, 2003; 63(4): 784 - 790.
[Abstract] [Full Text] [PDF]